Effect of tramadol on behavioral alterations and lipid peroxidation after transient forebrain ischemia in rats

Toxicology Mechanisms and Methods

Volumn 22, Issue 9, 2012, Pages 674-678

  Nagakannan, Pandian ^a   Shivasharan, Basavaraj D ^a   Thippeswamy, Boreddy S ^a   Veerapur, Veeresh P ^a  

^a SREE SIDDAGANGA COLLEGE OF PHARMACY   (India)

Author keywords

Forebrain ischemia; Neuroprotective; NMDA antagonist; Opioid agonist; Sensorimotor function; Tramadol

Indexed keywords

TRAMADOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; BRAIN HOMOGENATE; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; DRUG ACTIVITY; GRIP STRENGTH; LIPID PEROXIDATION; LOCOMOTION; MALE; MOTOR COORDINATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; WALKING;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ISCHEMIC ATTACK, TRANSIENT; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; RATS; RATS, WISTAR; REPERFUSION INJURY; TRAMADOL;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84867227284     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.716092     Document Type: Article

References (30)

1. Akhtar M, Pillai K, Vohora D. 2008. Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model of focal cerebral ischemia in rats. Hum Exp Toxicol 27:761-767.
2. Bhardwaj R, Mishra KC. 2004. N-Methyl-d-aspartate (NMDA) receptor antagonists as potential therapeutic agents in neurodegenerative diseases. Indian J Pharmacol 38:50-51.
3. Bilir A, Erkasap N, Koken T, Gulec S, Kaygisiz Z, Tanriverdi B, Kurt I. 2007. Effects of tramadol on myocardial ischemia-reperfusion injury. Scand Cardiovasc J 41:242-247.
4. Boyeson MG, Callister TR, Cavazos JE. 1992. Biochemical and behavioral effects of a sensorimotor cortex injury in rats pretreated with the noradrenergic neurotoxin DSP-4. Behav Neurosci 106:964-973.
5. Driessen B, Reimann W, Giertz H. 1993. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 108:806-811.
6. Ginsberg MD. 2008. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55:363-389.
7. Hara K, Minami K, Sata T. 2005. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyld-aspartate receptors expressed in Xenopus oocytes. Anesth Analg 100:1400-1405.
8. Haeseler G, Foadi N, Ahrens J, Dengler R, Hecker H, Leuwer M. 2006. Tramadol, fentanyl and sufentanil but not morphine block voltageoperated sodium channels. Pain 126:234-244.
9. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA. 2000. Functional assessments in mice and rats after focal stroke. Neuropharmacology 39:806-816.
10. Iglesias M, Segura MF, Comella JX, Olmos G. 2003. Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44:482-492.
11. Jingtao J, Sato S, Yamanaka N. 1999. Changes in cerebral blood flow and blood brain barrier in the gerbil hippocampal CA1 region following repeated brief cerebral ischemia. Med Electron Microsc 32:175-183.
12. Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69.
13. Kubo K, Nakao S, Jomura S, Sakamoto S, Miyamoto E, Xu Y, Tomimoto H, Inada T, Shingu K. 2009. Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats. Brain Res 1279:139-146.
14. Kulkarni SK. 1999. Hand book of experimental pharmacology. New Delhi: Vallabh Prakashan.
15. Lehotský J, Racay P, Pavlíková M, Tatarková Z, Urban P, Chomová M, Kovalská M, Kaplán P. 2009. Cross-talk of intracellular calcium stores in the response to neuronal ischemia and ischemic tolerance. Gen Physiol Biophys 28:F104-F114.
16. Lin-Zhong Z, Zheng G. (2009). Tramadol reduces myocardial infarct size and expression and activation of nuclear factor kappa B in acute myocardial infarction in rats. Eur J Anaesthesiol 26:1048-1055.
17. Li-Ze X, Jing Y, Qiang W, Zhi-hong LU. 2007. Involvement of δ-and μ-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats. Chin Med J 120, 394-399.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
19. Manocha A, Sharma KK, Mediratta PK. 1998. Tramadol, a centrally acting opioid: anticonvulsant effect against maximal electroshock seizure in mice. Indian J Physiol Pharmacol 42:407-411.
20. Manocha A, Sharma KK, Mediratta PK. 2005. On the mechanism of anticonvulsant effect of tramadol in mice. Pharmacol Biochem Behav 82:74-81.
21. Moro MA, Cárdenas A, Hurtado O, Leza JC, Lizasoain I. 2004. Role of nitric oxide after brain ischaemia. Cell Calcium 36:265-275.
22. Olanow CW. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
23. Pehrson R, Stenman E, Andersson KE. 2003. Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction. Eur Urol 44:495-499.
24. Qureshi GA, Baig S, Sarwar M, Parvez SH. 2004. Neurotoxicity, oxidative stress and cerebrovascular disorders. Neurotoxicology 25:121-138.
25. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. 1992. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260:275-285.
26. Rogers DC, Campbell CA, Stretton JL, Mackay KB. 1997. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28:2060-2066.
27. Song YN, Li HZ, Zhu JN, Guo CL, Wang JJ. 2006. Histamine improves rat rota-rod and balance beam performances through H(2) receptors in the cerebellar interpositus nucleus. Neuroscience 140:33-43.
28. Won SJ, Kim DY, Gwag BJ. 2002. Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 35:67-86.
29. Yan XB, Wang SS, Hou HL, Ji R, Zhou JN. 2007. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res 177:282-289.
30. Zhang Z, Chen TY, Kirsch JR, Toung TJ, Traystman RJ, Koehler RC, Hurn PD, Bhardwaj A. 2003. Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats. Anesth Analg 97:1776-1783.